Pharmacogenomics has been used in facilities across the country such as Mayo Clinic for some time now, it has recently become available for clinicians. Health insurers have recognized the benefits of this personalized medicine approach and are rapidly bringing it to the attention of practitioners and pharmaceutical companies
Central Medical has contracted with the industries top labs providing cutting edge genetic testing. This testing allows physicians of any type to assess how well a specific patient will metabolize and react to specific prescribed medications. This science is backed by the FDA and stemmed from the Human Genome Project.
